Developing a comparative docking protocol for the prediction of peptide selectivity profiles: Investigation of potassium channel toxins

Toxins

Volumn 4, Issue 2, 2012, Pages 110-138

  Chen, Po Chia ^a   Kuyucak, Serdar ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

kTX; Comparative docking; HADDOCK; K v1.1; K v1.2; K v1.3; Protein protein docking; Scorpion toxins; Selectivity

Indexed keywords

CONOTOXIN; POTASSIUM CHANNEL; POTASSIUM CHANNEL KV1.1; POTASSIUM CHANNEL KV1.2; POTASSIUM CHANNEL KV1.3; POTASSIUM CHANNEL KV1.4; POTASSIUM CHANNEL KV1.6; SCORPION VENOM;

ARTICLE; BINDING AFFINITY; COMPARATIVE STUDY; COMPUTER PROGRAM; CONTROLLED STUDY; ENERGY TRANSFER; MOLECULAR DOCKING; MOUSE; MUTAGENESIS; NONHUMAN; PREDICTION; PROCESS DEVELOPMENT; PROTEIN PROTEIN INTERACTION; RAT; TOXICITY TESTING; TOXIN ANALYSIS;

AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; COMPUTER SIMULATION; CONOTOXINS; HYDROGEN BONDING; MICE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PEPTIDES; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS, VOLTAGE-GATED; PROTEIN BINDING; PROTEIN CONFORMATION; RATS; SCORPION VENOMS; SOFTWARE;

SCORPIONES;

EID: 84863393842     PISSN: None     EISSN: 20726651     Source Type: Journal    
DOI: 10.3390/toxins4020110     Document Type: Article

References (77)

1. Mouhat, S.; Andreotti, N.; Jouirou, B.; Sabatier, J.M. Animal toxins acting on voltage-gated potassium channels. Curr. Pharmaceut. Des. 2008, 14, 2503-2518.
2. Norton, R.; Pennington, M.; Wulff, H. Potassium channel blockade by the sea anemone toxin ShK for the treatment of multiple sclerosis and other autoimmune diseases. Curr. Med. Chem. 2004, 11, 3041-3052.
3. Judge, S.; Bever, C. Potassium channel blockers in multiple sclerosis: Neuronal K-V channels and effects of symptomatic treatment. Pharmacol. Therapeut. 2006, 111, 224-259.
4. Bradding, P.;Wulff, H. The K+ channels K(Ca)3.1 and K(v)1.3 as novel targets for asthma therapy. Brit. J. Pharmacol. 2009, 157, 1330-1339.
5. Rasband, M.; Park, E.; Vanderah, T.; Lai, J.; Porreca, F.; Trimmer, J. Distinct potassium channels on pain-sensing neurons. Proc. Natl. Acad. Sci. USA 2001, 98, 13373-13378.
6. Takeda, M.; Tsuboi, Y.; Kitagawa, J.; Nakagawa, K.; Iwata, K.; Matsumoto, S. Potassium channels as a potential therapeutic target for trigeminal neuropathic and inflammatory pain. Mol. Pain 2011, 7.
7. Harvey, A. Twenty years of dendrotoxins. Toxicon 2001, 39, 15-26.
8. Huang, P.T.; Shiau, Y.S.; Lou, K.L. The interaction of spider gating modifier peptides with voltage-gated potassium channels. Toxicon 2007, 49, 285-292.
9. de la Vega, R.; Possani, L. Current views on scorpion toxins specific for K+-channels. Toxicon 2004, 43, 865-875.
10. Castaneda, O.; Sotolongo, V.; Amor, A.; Stocklin, R.; Anderson, A.; Harvey, A.; Engstrom, A.; Wernstedt, C.; Karlsson, E. Characterization of a potassium channel toxin from the Caribbean sea-anemone Stichodactyla-helianthus. Toxicon 1995, 33, 603-613.
11. Terlau, H.; Olivera, B. Conus venoms: A rich source of novel ion channel-targeted peptides. Physiol. Rev. 2004, 84, 41-68.
12. Tytgat, J.; Chandy, K.; Garcia, M.; Gutman, G.; Martin-Eauclaire, M.; van der Walt, J.; Possani, L. A unified nomenclature for short-chain peptides isolated from scorpion venoms: alpha-KTx molecular subfamilies. Trends Pharmacol. Sci. 1999, 20, 444-447.
13. Castle, N.; London, D.; Creech, C.; Fajloun, Z.; Stocker, J.; Sabatier, J. Maurotoxin: A potent inhibitor of intermediate conductance Ca2+-activated potassium channels. Mol. Pharmacol. 2003, 63, 409-418.
14. Giangiacomo, K.M.; Ceralde, Y.; Mullmann, T.J. Molecular basis of [alpha]-KTx specificity. Toxicon 2004, 43, 877-886.
15. Gao, Y.; Garcia, M. Interaction of agitoxin2, charybdotoxin, and iberiotoxin with potassium channels: Selectivity between voltage-gated and Maxi-K channels. Proteins Struct. Func. Genet. 2003, 52, 146-154.
16. Giangiacomo, K.M.; Becker, J.; Garsky, C.; Felix, J.P.; Priest, B.T.; Schmalhofer, W.; Garcia, M.L.; Mullmann, T.J. Revealing the molecular determinants of neurotoxin specificity for calcium-activated versus voltage-dependent potassium channels. Biochemistry 2007, 46, 5358-5364.
17. Rauer, H.; Lanigan, M.; Pennington, M.; Aiyar, J.; Ghanshani, S.; Cahalan, M.; Norton, R.; Chandy, K. Structure-guided transformation of charybdotoxin yields an analog that selectively targets Ca2+-activated over voltage-gated K+ channels. J. Biol. Chem. 2000, 275, 1201-1208.
18. Corzo, G.; Papp, F.; Varga, Z.; Barraza, O.; Espino-Solis, P.G.; Rodriguez de la Vega, R.C.; Gaspar, R.; Panyi, G.; Possani, L.D. A selective blocker of Kv1.2 and Kv1.3 potassium channels from the venom of the scorpion Centruroides suffusus suffusus. Biochem. Pharmacol. 2008, 76, 1142-1154.
19. Eriksson, M.; Roux, B. Modeling the structure of Agitoxin in complex with the Shaker K+ channel: A computational approach based on experimental distance restraints extracted from thermodynamic mutant cycles. Biophys. J. 2002, 83, 2595-2609.
20. M'Barek, S.; Lopez-Gonzalez, I.; Andreotti, N.; di Luccio, E.; Visan, V.; Grissmer, S.; Judge, S.; El Ayeb, M.; Darbon, H.; Rochat, H.; Sampieri, F.; Beraud, E.; Fajloun, Z.; De Waard, M.; Sabatier, J. A maurotoxin with constrained standard disulfide bridging-Innovative strategy of chemical synthesis, pharmacology, and docking on K+ channels. J. Biol. Chem. 2003, 278, 31095-31104.
21. Han, S.; Yi, H.; Yin, S.J.; Chen, Z.Y.; Liu, H.; Cao, Z.J.; Wu, Y.L.; Li, W.X. Structural basis of a potent peptide inhibitor designed for Kv1.3 channel, a therapeutic target of autoimmune disease. J. Biol. Chem. 2008, 283, 19058-19065.
22. Jouirou, B.; Mosbah, A.; Visan, V.; Grissmer, S.; M'Barek, S.; Fajloun, Z.; Van Rietschoten, J.; Devaux, C.; Rochat, H.; Lippens, G.; El Ayeb, M.; De Waard, M.; Mabrouk, K.; Sabatier, J. Cobatoxin 1 from Centruroides noxius scorpion venom: chemical synthesis, three-dimensional structure in solution, pharmacology and docking on K+ channels. Biochem. J. 2004, 377, 37-49.
23. Moreira, I.S.; Fernandes, P.A.; Ramos, M.J. Protein-Protein Docking Dealing With the Unknown. J. Comput. Chem. 2010, 31, 317-342.
24. Abagyan, R.; Totrov M.; Kuznetsov, D. ICM-A new method for protein modelling and design-applications to docking and structure prediction from the distorted native conformations. J. Comput. Chem. 1994, 15, 488-506.
25. Dominguez, C.; Boelens, R.; Bonvin, A. HADDOCK: A protein-protein docking approach based on biochemical or biophysical information. J. Am. Chem. Soc. 2003, 125, 1731-1737.
26. Pierce, B.; Weng, Z. ZRANK: Reranking protein docking predictions with an optimized energy function. Proteins Struct. Func. Bioinf. 2007, 67, 1078-1086.
27. Wang, C.; Bradley, P.; Baker, D. Protein-protein docking with backbone flexibility. J Mol. Biol. 2007, 373, 503-519.
28. Janin, J.; Wodak, S. The Third CAPRI Assessment Meeting-Toronto, Canada, April 20-21, 2007. Structure 2007, 15, 755-759.
29. Chaudhury, S.; Gray, J.J. Conformer selection and induced fit in flexible backbone protein-protein docking using computational and NMR ensembles. J Mol. Biol. 2008, 381, 1068-1087.
30. Park, I.H.; Li, C. Dynamic Ligand-Induced-Fit Simulation via Enhanced Conformational Samplings and Ensemble Dockings: A Survivin Example. J. Phys. Chem. B 2010, 114, 5144-5153.
31. Bonvin, A. Flexible protein-protein docking. Curr. Opin. Struct. Biol. 2006, 16, 194-200.
32. Andrusier, N.; Mashiach, E.; Nussinov, R.; Wolfson, H.J. Principles of flexible protein-protein docking. Proteins Struct. Func. Bioinf. 2008, 73, 271-289.
33. Mobley, D.L.; Dill, K.A. Binding of Small-Molecule Ligands to Proteins: "What You See" Is Not Always What You Get. Structure 2009, 17, 489-498, doi:10.1016/j.str.2009.02.010.
34. Doudou, S.; Burton, N.A.; Henchman, R.H. Standard Free Energy of Binding from a One-Dimensional Potential of Mean Force. J. Chem. Theory Comput. 2009, 5, 909-918.
35. Wang, R.; Lai, L.; Wang, S. Further development and validation of empirical scoring functions for structure-based binding affinity prediction. J. Comput.-Aided Mol. Des. 2002, 16, 11-26.
36. Sousa, S.F.; Fernandes, P.A.; Ramos, M.J. Protein-ligand docking: Current status and future challenges. Proteins Struct. Func. Bioinf. 2006, 65, 15-26.
37. Alonso, H.; Bliznyuk, A.A.; Gready, J.E. Combining docking and molecular dynamic simulations in drug design. Med. Res. Rev. 2006, 26, 531-568.
38. de Vries, S.J.; van Dijk, A.D.J.; Krzeminski, M.; van Dijk, M.; Thureau, A.; Hsu, V.; Wassenaar, T.; Bonvin, A.M.J.J. HADDOCK versus HADDOCK: New features and performance of HADDOCK2.0 on the CAPRI targets. Proteins Struct. Func. Bioinf. 2007, 69, 726-733.
39. Phillips, J.; Braun, R.; Wang, W.; Gumbart, J.; Tajkhorshid, E.; Villa, E.; Chipot, C.; Skeel, R.; Kale, L.; Schulten, K. Scalable molecular dynamics with NAMD. J. Comput. Chem. 2005, 26, 1781-1802.
40. Humphrey, W.; Dalke, A.; Schulten, K. VMD: Visual molecular dynamics. J. Mol. Graph. 1996, 14, 33-&.
41. Olamendi-Portugal, T.; Somodi, S.; Fernandez, J.; Zamudio, F.; Becerril, B.; Varga, Z.; Panyi, G.; Gaspar, R.; Possani, L. Novel alpha-KTx peptides from the venom of the scorpion Centruroides elegans selectively blockade Kv1.3 over IKCa1K(+) channels of T cells. Toxicon 2005, 46, 418-429.
42. RomiLebrun, R.; Lebrun, B.; MartinEauclaire, M.; Ishiguro, M.; Escoubas, P.; Wu, F.; Hisada, M.; Pongs, O.; Nakajima, T. Purification, characterization, and synthesis of three novel toxins from the Chinese scorpion Buthus martensi, which act on K+ channels. Biochemistry 1997, 36, 13473-13482.
43. Dauplais, M.; Gilquin, B.; Possani, L.; GurrolaBriones, G.; Roumestand, C.; Menez, A. Determination of the three-dimensional solution structure of noxiustoxin: Analysis of structural differences with related short-chain scorpion toxins. Biochemistry 1995, 34, 16563-16573.
44. Grissmer, S.; Nguyen, A.; Aiyar, J.; Hanson, D.; Mather, R.; Gutman, G.; Karmilowicz, M.; Auperin, D.; Chandy, K. Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines. Mol. Pharmacol. 1994, 45, 1227-1234.
45. Leonard, R.; Garcia, M.; Slaughter, R.; Reuben, J. Selective blockers of voltage-gated K+ channels depolarize human lymphocyte-T-mechanism of the antiproliferative effect of charybdotoxin. Proc. Natl. Acad. Sci. USA 1992, 89, 10094-10098.
46. Long, S.B.; Tao, X.; Campbell, E.B.; MacKinnon, R. Atomic structure of a voltage-dependent K+ channel in a lipid membrane-like environment. Nature 2007, 450, 376-U3.
47. Koschak, A.; Bugianesi, R.; Mitterdorfer, J.; Kaczorowski, G.; Garcia, M.; Knaus, H. Subunit composition of brain voltage-gated potassium channels determined by hongotoxin-1, a novel peptide derived from Centruroides limbatus venom. J. Biol. Chem. 1998, 273, 2639-2644.
48. Garcia, M.; Garcia-Calvo, M.; Hidalgo, P.; Lee, A.; MacKinnon, R. Purification and characterization of 3 inhibitors of voltage-dependent K+ channels from Leiurus-quinquestriatus var hebraeus venom. Biochemistry 1994, 33, 6834-6839.
49. Pimentel, C.; M'barek, S.; Visan, V.; Grissmer, S.; Sampieri, F.; Sabatier, J.M.; Darbon, H.; Fajloun, Z. Chemical synthesis and H-1-NMR 3D structure determination of AgTx2-MTX chimera, a new potential blocker for Kv1.2 channel, derived from MTX and AgTx2 scorpion toxins. Prot. Sci. 2008, 17, 107-118.
50. Mouhat, S.; Visan, V.; Ananthakrishnan, S.; Wulff, H.; Andreotti, N.; Grissmer, S.; Darbon, H.; De Waard, M.; Sabatier, J.M. K+ channel types targeted by synthetic OSK1, a toxin from Orthochirus scrobiculosus scorpion venom. Biochem. J. 2005, 385, 95-104.
51. Hopkins, W. Toxin and subunit specificity of blocking affinity of three peptide toxins for heteromultimeric, voltage-gated potassium channels expressed in Xenopus oocytes. J. Pharmacol. Exp. Therapeut. 1998, 285, 1051-1060.
52. Rodrigues, A.; Arantes, E.; Monje, F.; Stuhmer, W.; Varanda, W. Tityustoxin-K(alpha) blockade of the voltage-gated potassium channel Kv1.3. Brit. J. Pharmacol. 2003, 139, 1180-1186.
53. Fajloun, Z.; Carlier, E.; Lecomte, C.; Geib, S.; di Luccio, E.; Bichet, D.; Mabrouk, K.; Rochat, H.; De Waard, M.; Sabatier, J. Chemical synthesis and characterization of Pi1, a scorpion toxin from Pandinus imperator active on K+ channels. Eur. J. Biochem. 2000, 267, 5149-5155.
54. Regaya, I.; Beeton, C.; Ferrat, G.; Andreotti, N.; Darbon, H.; De Waard, M.; Sabatier, J. Evidence for domain-specific recognition of SK and Kv channels by MTX and HsTx1 scorpion toxins. J. Biol. Chem. 2004, 279, 55690-55696.
55. Fajloun, Z.; Ferrat, G.; Carlier, E.; Fathallah, M.; Lecomte, C.; Sandoz, G.; di Luccio, E.; Mabrouk, K.; Legros, C.; Darbon, H.; Rochat, H.; Sabatier, J.; De Waard, M. Synthesis, H-1 NMR structure, and activity of a three-disulfide-bridged maurotoxin analog designed to restore the consensus motif of scorpion toxins. J. Biol. Chem. 2000, 275, 13605-13612.
56. Kharrat, R.; Mansuelle, P.; Sampieri, F.; Crest, M.; Oughideni, R.; VanRietschoten, J.; MartinEauclaire, M.; Rochat, H.; ElAyeb, M. Maurotoxin, a four disulfide bridge toxin from Scorpio maurus venom: Purification, structure and action on potassium channels. FEBS Lett. 1997, 406, 284-290.
57. M'Barek, S.; Chagot, B.; Andreotti, N.; Visan, V.; Mansuelle, P.; Grissmer, S.; Marrakchi, M.; El Ayeb, M.; Sampieri, F.; Darbon, H.; Fajoun, Z.; DeWaard, M.; Sabatier, J. Increasing the molecular contacts between maurotoxin and Kv1.2 channel augments ligand affinity. Proteins Struct. Func. Bioinf. 2005, 60, 401-411.
58. Carrega, L.; Mosbah, A.; Ferrat, G.; Beeton, C.; Andreotti, N.; Mansuelle, P.; Darbon, H.; De Waard, M.; Sabatier, J. The impact of the fourth disulfide bridge in scorpion toxins of the alpha-KTx6 subfamily. Proteins Struct. Func. Bioinf. 2005, 61, 1010-1023.
59. M'Barek, S.; Mosbah, A.; Sandoz, G.; Fajloun, Z.; Olamendi-Portugal, T.; Rochat, H.; Sampieri, F.; Guijarro, J.; Mansuelle, P.; Delepierre, M.; De Waard, M.; Sabatier, J. Synthesis and characterization of Pi4, a scorpion toxin from Pandinus imperator that acts on K+ channels. Eur. J. Biochem. 2003, 270, 3583-3592.
60. Rogowski, R.; Collins, J.; ONeill, T.; Gustafson, T.; Werkman, T.; Rogawski, M.; Tenenholz, T.; Weber, D.; Blaustein, M. Three new toxins from the scorpion Pandinus imperator selectively block certain voltage-gated K+ channels. Mol. Pharmacol. 1996, 50, 1167-1177.
61. Peter, M.; Varga, Z.; Panyi, G.; Bene, L.; Damjanovich, S.; Pieri, C.; Possani, L.; Gaspar, R. Pandinus imperator scorpion venom blocks voltage-gated K+ channels in human lymphocytes. Biochem. Biophys. Res. Commun. 1998, 242, 621-625.
62. Takacs, Z.; Toups, M.; Kollewe, A.; Johnson, E.; Cuello, L.G.; Driessens, G.; Biancalana, M.; Koide, A.; Ponte, C.G.; Perozo, E.; Gajewski, T.F.; Suarez-Kurtz, G.; Koide, S.; Goldstein, S.A.N. A designer ligand specific for Kv1.3 channels from a scorpion neurotoxin-based library. Proc. Natl. Acad. Sci. USA 2009, 106, 22211-22216.
63. Mouhat, S.; De Waard, M.; Sabatier, J. Contribution of the functional dyad of animal toxins acting on voltage-gated Kv1-type channels. J. Pept. Sci. 2005, 11, 65-68.
64. Yu, L.; Sun, C.; Song, D.; Shen, J.; Xu, N.; Gunasekera, A.; Hajduk, P.; Olejniczak, E. Nuclear magnetic resonance structural studies of a potassium channel-charybdotoxin complex. Biochemistry 2005, 44, 15834-15841.
65. Bas, D.C.; Rogers, D.M.; Jensen, J.H. Very fast prediction and rationalization of pKa values for protein-ligand complexes. Proteins Struct. Func. Bioinf. 2008, 73, 765-783.
66. Ranganathan, R.; Lewis, J.; MacKinnon, R. Spatial localization of the K+ channel selectivity filter by mutant cycle-based structure analysis. Neuron 1996, 16, 131-139.
67. Aiyar, J.; Rizzi, J.; Gutman, G.; Chandy, K. The signature sequence of voltage-gated potassium channels projects into the external vestibule. J. Biol. Chem. 1996, 271, 31013-31016.
68. Visan, V.; Fajloun, Z.; Sabatier, J.; Grissmer, S. Mapping of maurotoxin binding sites on hKv1.2, hKv1.3, and hIKCa1 channels. Mol. Pharmacol. 2004, 66, 1103-1112.
69. Kastritis, P.L.; Bonvin, A.M.J.J. Are Scoring Functions in Protein-Protein Docking Ready To Predict Interactomes? Clues from a Novel Binding Affinity Benchmark. J. Proteome Res. 2010, 9, 2216-2225.
70. Chen, P.C.; Kuyucak, S. Mechanism and Energetics of Charybdotoxin Unbinding from a Potassium Channel from Molecular Dynamics Simulations. Biophys. J. 2009, 96, 2577-2588.
71. Chen, P.C.; Kuyucak, S. Accurate Determination of the Binding Free Energy for KcsA-Charybdotoxin Complex from the Potential of Mean Force Calculations with Restraints. Biophys. J. 2011, 100, 2466-2474.
72. Abbas, N.; Belghazi, M.; Abdel-Mottaleb, Y.; Tytgat, J.; Bougis, P.E.; Martin-Eauclaire, M.F. A new Kaliotoxin selective towards Kv1.3 and Kv1.2 but not Kv1.1 channels expressed in oocytes. Biochem. Biophys. Res. Commun. 2008, 376, 525-530.
73. Abdel-Mottaleb, Y.; Vandendriessche, T.; Clynen, E.; Landuyt, B.; Jalali, A.; Vatanpour, H.; Schoofs, L.; Tytgat, J. OdK2, a Kv1.3 channel-selective toxin from the venom of the Iranian scorpion Odonthobuthus doriae. Toxicon 2008, 51, 1424-1430.
74. Payandeh, J.; Scheuer, T.; Zheng, N.; Catterall, W.A. The crystal structure of a voltage-gated sodium channel. Nature 2011, 475, 353-U104.
75. Billen, B.; Bosmans, F.; Tytgat, J. Animal peptides targeting voltage-activated sodium channels. Curr. Pharmaceut. Des. 2008, 14, 2492-2502.
76. Xue, T.; Ennis, I.; Sato, K.; French, R.; Li, R. Novel interactions identified between mu-conotoxin and the Na(+) channel domain IP-loop: Implications for toxin-pore binding geometry. Biophys. J. 2003, 85, 2299-2310.
77. Deval, E.; Gasull, X.; Noel, J.; Salinas, M.; Baron, A.; Diochot, S.; Lingueglia, E. Acid-Sensing Ion Channels (ASICs): Pharmacology and implication in pain. Pharmacol. Therapeut. 2010, 128, 549-558.